drugset / Trial / NCT06584058

HPP737 Substance Balance Study in Human

NCT06584058

Not yet recruiting 8 enrolled Newsoara Biopharma Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

Main research purpose 1. Quantitative analysis of the total amount of radioactivity in excreta (urine and feces) of male healthy subjects after oral administration of \[14C\]HPP737, to obtain the cumulative excretion rate and main excretion routes of human radioactivity; 2. To identify the main metabolites in the offspring of \[14C\]HPP737 in healthy male subjects, and to determine the main biotransformation pathway and main metabolite structure; 3. To investigate the distribution of total radioactivity in whole blood and plasma and the pharmacokinetics of total plasma radioactivity in healthy male subjects after a single oral administration of \[14C\]HPP737. Participants will: 1. Take Investigational product once 2. Stay in the clinic about 7 days for checkups and tests 3. Report their symptoms

Timeline

Start
2024-08-30
Primary completion
2025-07-30
Completion
2025-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HPP737 Unknown 20 mg Oral

Indications